Financials Globe Life Inc.

Equities

GL

US37959E1029

Life & Health Insurance

Market Closed - Nyse 04:00:01 2024-04-26 pm EDT 5-day change 1st Jan Change
75.75 USD +0.28% Intraday chart for Globe Life Inc. +13.50% -37.77%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 11,397 9,939 9,464 11,726 11,456 7,123 - -
Enterprise Value (EV) 1 13,045 11,862 11,490 13,803 13,572 9,853 10,344 10,857
P/E ratio 15.4 x 13.9 x 13 x 16.1 x 12.1 x 6.57 x 5.94 x 5.42 x
Yield 0.66% 0.79% 0.84% 0.69% 0.74% 1.19% 1.2% 1.14%
Capitalization / Revenue 2.52 x 2.1 x 1.85 x 2.25 x 2.1 x 1.22 x 1.17 x 1.11 x
EV / Revenue 2.88 x 2.5 x 2.25 x 2.65 x 2.49 x 1.69 x 1.7 x 1.7 x
EV / EBITDA 12.6 x 11.9 x 11.3 x - - 6.61 x 6.89 x 6.98 x
EV / FCF - - - - - 21.9 x - -
FCF Yield - - - - - 4.57% - -
Price to Book 1.59 x 1.14 x 1.09 x 2.43 x 2.58 x 1.25 x 1.06 x 0.87 x
Nbr of stocks (in thousands) 108,288 104,662 100,979 97,270 94,119 94,037 - -
Reference price 2 105.2 94.96 93.72 120.6 121.7 75.75 75.75 75.75
Announcement Date 2/4/20 2/2/21 2/2/22 2/1/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,528 4,738 5,113 5,215 5,448 5,820 6,089 6,392
EBITDA 1 1,032 1,000 1,016 - - 1,491 1,501 1,556
EBIT 1 - 706.7 666.3 799.4 1,279 1,387 1,444 -
Operating Margin - 14.92% 13.03% 15.33% 23.47% 23.83% 23.72% -
Earnings before Tax (EBT) 1 - - - - 1,194 1,328 1,445 1,546
Net income 1 760.8 731.8 745 739.7 970.8 1,081 1,147 1,222
Net margin 16.8% 15.45% 14.57% 14.18% 17.82% 18.57% 18.83% 19.12%
EPS 2 6.830 6.820 7.220 7.470 10.07 11.53 12.74 13.98
Free Cash Flow 1 - - - - - 450 - -
FCF margin - - - - - 7.73% - -
FCF Conversion (EBITDA) - - - - - 30.18% - -
FCF Conversion (Net income) - - - - - 41.64% - -
Dividend per Share 2 0.6900 0.7500 0.7900 0.8300 0.9000 0.9000 0.9100 0.8600
Announcement Date 2/4/20 2/2/21 2/2/22 2/1/23 2/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,278 1,297 1,308 1,293 1,291 1,323 1,321 1,326 1,384 1,416 1,416 1,447 1,464 1,480 1,506
EBITDA - - - - - - - - - - - - - - -
EBIT 1 173.4 159.4 159.3 206 215.8 218.4 311 315.4 324.3 327.8 324.4 346.1 350.4 352.1 340.2
Operating Margin 13.57% 12.29% 12.17% 15.93% 16.71% 16.51% 23.54% 23.78% 23.43% 23.16% 22.9% 23.91% 23.94% 23.79% 22.59%
Earnings before Tax (EBT) 1 - 217.6 201.6 217 230 257.7 274.2 264.5 318.8 336.7 314.9 340.9 348 353.2 352.2
Net income 1 - 178 164.4 177 186.8 211.6 223.6 215.3 257.1 274.8 254.2 271.2 274.9 279.1 281.2
Net margin - 13.72% 12.56% 13.69% 14.46% 15.99% 16.92% 16.23% 18.57% 19.41% 17.95% 18.74% 18.78% 18.86% 18.67%
EPS 2 1.840 1.760 1.640 1.790 1.900 2.140 2.280 2.240 2.680 2.880 2.670 2.872 2.954 3.024 3.060
Dividend per Share 2 0.1975 0.1975 0.2075 0.2075 0.2075 0.2075 0.2250 0.2250 0.2250 0.2250 0.2367 0.2400 0.2400 0.2400 0.2400
Announcement Date 10/20/21 2/2/22 4/20/22 7/27/22 10/26/22 2/1/23 5/3/23 7/26/23 10/25/23 2/7/24 4/22/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,648 1,923 2,026 2,077 2,116 2,729 3,221 3,734
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.597 x 1.922 x 1.994 x - - 1.83 x 2.146 x 2.399 x
Free Cash Flow 1 - - - - - 450 - -
ROE (net income / shareholders' equity) 11.6% 9.5% 8.13% 10.9% 24.3% 21.7% 19.1% 15.4%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 66.00 83.20 86.00 49.70 47.10 60.70 71.60 87.10
Cash Flow per Share - 13.80 13.90 14.40 - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 2/4/20 2/2/21 2/2/22 2/1/23 2/7/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
75.75 USD
Average target price
110.6 USD
Spread / Average Target
+45.95%
Consensus
  1. Stock Market
  2. Equities
  3. GL Stock
  4. Financials Globe Life Inc.